Copy
Trading Bots
Events
More

Bitwise XRP ETF Surpasses $200M in 2025 Inflows

2026/06/23 14:30Browse 0

Institutional demand for XRP, the cryptocurrency linked to the Ripple network, continues to accelerate. Bitwise Asset Management CEO Hunter Horsley announced that XRP exchange-traded products in the US and Europe have exceeded $200 million in year-to-date net inflows. The Bitwise XRP ETF, trading on the New York Stock Exchange under tickers such as XRP or 1XRP, debuted in late 2025 and holds spot XRP in cold storage, offering regulated exposure to the token. Its market capitalization now stands at $256.85 million.

European and US Product Suite

Before the US launch, Bitwise introduced the Bitwise Physical XRP ETP (ticker GXRP) on Germany's Xetra in April 2022, well ahead of SEC-approved spot ETFs. Each unit of the European fund represents a claim on a fixed amount of XRP. Together, these products have attracted significant capital, with the US ETF alone contributing to the $200 million milestone.

Steady Weekly Inflows

Despite broader market headwinds, XRP ETF inflows have remained consistent. On June 22, total spot XRP ETF inflows reached $4.72 million, following $2.15 million on June 18 and $4.28 million on June 16. The largest single-day inflow in June was $6.37 million on June 9. Among issuers, Franklin Templeton's XRPZ led with $6.69 million, while Bitwise's product added $3.97 million. Cumulative inflows have pushed the global spot XRP ETF market capitalization past $722 million.

Disclaimer: This page may contain third-party information and does not necessarily reflect BYDFi's views or opinions. This content is for general reference only and does not constitute any representation, warranty, financial advice, or investment advice. BYDFi is not responsible for any errors, omissions, or any results arising from the use of such information. Virtual asset investments involve risks. Please carefully evaluate the risks of the product and your risk tolerance based on your financial situation. For more information, please refer to our Terms of Use and Risk Disclosure.